
OrthoPediatrics launched a new RESPONSE Rib and Pelvic Fixation system to treat children with Early Onset Scoliosis (EOS). This represents the company’s 71st system to treat orthopedic conditions in pediatric patients.
The new addition to the RESPONSE family includes implants and instruments for rib and pelvic fixation, and associated devices to connect the fixation points. The system also features a range of implant options, low profile implants, range of motion rib hooks and locking options. As an adjunct to the foundational RESPONSE Scoliosis System, the Rib and Pelvic system is compatible with 5.5/6.0 and 4.5/5.0 RESPONSE Systems, allowing surgeons to treat the entire spectrum of patients with scoliosis.
Greg Odle, President of the OrthoPediatrics’ Scoliosis Division, said, “We are excited to enter the Early Onset Scoliosis treatment market with the RESPONSE Rib & Pelvic System. While this is our first treatment option in the EOS market, we continue to work with pediatric orthopedic surgeons to develop additional treatment options for EOS patients.”
Source: OrthoPediatrics Corp.
OrthoPediatrics launched a new RESPONSE Rib and Pelvic Fixation system to treat children with Early Onset Scoliosis (EOS). This represents the company’s 71st system to treat orthopedic conditions in pediatric patients.
The new addition to the RESPONSE family includes implants and instruments for rib and pelvic fixation, and associated devices...
OrthoPediatrics launched a new RESPONSE Rib and Pelvic Fixation system to treat children with Early Onset Scoliosis (EOS). This represents the company’s 71st system to treat orthopedic conditions in pediatric patients.
The new addition to the RESPONSE family includes implants and instruments for rib and pelvic fixation, and associated devices to connect the fixation points. The system also features a range of implant options, low profile implants, range of motion rib hooks and locking options. As an adjunct to the foundational RESPONSE Scoliosis System, the Rib and Pelvic system is compatible with 5.5/6.0 and 4.5/5.0 RESPONSE Systems, allowing surgeons to treat the entire spectrum of patients with scoliosis.
Greg Odle, President of the OrthoPediatrics’ Scoliosis Division, said, “We are excited to enter the Early Onset Scoliosis treatment market with the RESPONSE Rib & Pelvic System. While this is our first treatment option in the EOS market, we continue to work with pediatric orthopedic surgeons to develop additional treatment options for EOS patients.”
Source: OrthoPediatrics Corp.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.